Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning the Methods and Compositions for Treating Status Epilepticus and Seizures Causing Status Epilepticus, 34968-34969 [2011-14801]

Download as PDF 34968 Federal Register / Vol. 76, No. 115 / Wednesday, June 15, 2011 / Notices 96814–4700; phone (808) 944–2200; fax (808) 973–2941. Written comments or requests for a public hearing on this request should be submitted to the Chief, Permits, Conservation and Education Division, at the address listed above. Comments may also be submitted by facsimile to (301) 713–0376, or by e-mail to NMFS.Pr1Comments@noaa.gov. Please include the File No. in the subject line of the e-mail comment. Those individuals requesting a hearing should set forth the specific reasons why a hearing on this particular modification request would be appropriate. FOR FURTHER INFORMATION CONTACT: Amy Hapeman or Kristy Beard, (301) 713–2289. The subject modification to Permit No. 10027, issued on July 30, 2008 (73 FR 44224), is requested under the authority of the Endangered Species Act of 1973, as amended (16 U.S.C. 1531 et seq.) and the regulations governing the taking, importing, and exporting of endangered and threatened species (50 CFR 222– 226). The permit currently authorizes the permit holder to study the population biology and connectivity of green (Chelonia mydas) and hawksbill (Eretmochelys imbricata) sea turtles focusing on distribution and abundance, ecology, health, and threats to sea turtles at the Palmyra Atoll in the Pacific Ocean. The permit holder requests a modification to their existing permit to increase the number of green sea turtles taken annually from 100 to 250 turtles per year. Of the total 250 green sea turtles, researchers request to increase the number tagged with sonic transmitters from 30 to 40 turtles annually. The modification is needed to accommodate higher than anticipated capture rates and an increase in capture efforts. These data will help determine if temporal, stage-specific, or sexspecific movement patterns exist for the population of sea turtles at Palmyra. The modified permit would expire July 31, 2013. jlentini on DSK4TPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: Dated: June 10, 2011. Tammy C. Adams, Acting Chief, Permits, Conservation and Education Division, Office of Protected Resources, National Marine Fisheries Service. [FR Doc. 2011–14857 Filed 6–14–11; 8:45 am] BILLING CODE 3510–22–P VerDate Mar<15>2010 16:42 Jun 14, 2011 Jkt 223001 Department of the Army Intent to Grant an Exclusive License of U.S. Government-Owned Inventions April 20, 2011. The United States Government, as represented by the Secretary of the Army, has rights to this invention. ADDRESSES: DEPARTMENT OF DEFENSE Department of the Army, DoD. Notice. AGENCY: ACTION: In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7(a)(1)(i) and 37 CFR 404.7(b)(1)(i), announcement is made of the intent to grant an exclusive, revocable license to the invention claimed in the PCT/US2009/060091 (Publication Number WO 2010/042780), entitled ‘‘Methods and Compositions for Treating Status Epilepticus and Seizures Causing Status Epilepticus’’, to Biomedisyn Corporation with its principal place of business at 12 Indian Trail Road, Woodbridge, Connecticut 06525. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, MD 21702–5012. FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele, Office of Research & Technology Applications, (301) 619–6664. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808; both at telefax (301) 619– 5034. SUPPLEMENTARY INFORMATION: Anyone wishing to object to grant of this license can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Command Judge Advocate (see ADDRESSES). SUMMARY: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. FOR FURTHER INFORMATION CONTACT: The invention relates to a dynamic exoskeletal orthosis applied to the leg below the knee, designed to compensate for weakness, pain, and/or decreased range of motion at the ankle. SUPPLEMENTARY INFORMATION: Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2011–14803 Filed 6–14–11; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning the Methods and Compositions for Treating Status Epilepticus and Seizures Causing Status Epilepticus AGENCY: Department of the Army, DoD. Notice. Brenda S. Bowen, Army Federal Register Liaison Officer. ACTION: [FR Doc. 2011–14802 Filed 6–14–11; 8:45 am] SUMMARY: BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially; Exclusive Licensing of an Invention Concerning the Intrepid Dynamic Exoskeletal Orthosis Department of the Army, DoD. Notice. AGENCY: ACTION: Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/518,801, entitled ‘‘Intrepid Dynamic Exoskeletal Orthosis (IDEO),’’ filed on SUMMARY: PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 Announcement is made of the availability for licensing of the invention set forth in the PCT/US2009/ 060091, entitled ‘‘Methods and Compositions for Treating Status Epilepticus and Seizures Causing Status Epilepticus’’ filed on October 9, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention. U.S. and selected foreign rights are available. Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, MD 21702–5012. ADDRESSES: For licensing issues, Dr. Paul Mele, Office of Research & Technology Applications, (301) 619–6664. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) FOR FURTHER INFORMATION CONTACT: E:\FR\FM\15JNN1.SGM 15JNN1 Federal Register / Vol. 76, No. 115 / Wednesday, June 15, 2011 / Notices 619–7808, both at telefax (301) 619– 5034. Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2011–14801 Filed 6–14–11; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF EDUCATION [Docket ID ED–2011–OII–0001] Investing in Innovation Fund Office of Innovation and Improvement, Department of Education. ACTION: Notice announcing the location, dates, and times of pre-application meetings. AGENCY: Overview Information Investing in Innovation Fund Catalog of Federal Domestic Assistance (CFDA) Numbers: 84.411A (Scale-up grants), 84.411B (Validation grants), and 84.411C (Development grants). The Assistant Deputy Secretary for Innovation and Improvement announces preapplication meetings for the fiscal year (FY) 2011 Investing in Innovation Fund (i3) competition. The Department of Education (Department) published three notices inviting applications for the i3 program in the Federal Register on June 3, 2011 (76 FR 32148–32182). These notices include the priorities and selection criteria that the Department will use for the FY 2011 i3 competition. The Department published a separate notice inviting applications for each grant type—Scale-up, Validation, and Development—under the i3 program. FOR FURTHER INFORMATION CONTACT: Thelma Leenhouts, U.S. Department of Education, 400 Maryland Avenue, SW., Room 4W302, Washington, DC 20202– 5960. Telephone: (202) 453–7122; or by e-mail: i3@ed.gov. If you use a telecommunications device for the deaf (TDD) or a text telephone (TTY), call the Federal Relay Service, toll free, at 1–800–877–8339. SUPPLEMENTARY INFORMATION: The Department intends to hold preapplication meetings designed to provide technical assistance to interested applicants for all three types of i3 grants (Scale-up, Validation, and Development). The Department will hold two pre-application meetings on June 17, 2011, in Washington, DC, from 9:00 a.m. to 12:30 p.m. (Eastern Time) and from 1:30 p.m. to 5:00 p.m. (Eastern Time). The Department will also hold one pre-application meeting on June 24, 2011, in San Francisco, California, from jlentini on DSK4TPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 16:42 Jun 14, 2011 Jkt 223001 10:00 a.m. to 2:00 p.m. (Pacific Time). The Department will hold another preapplication meeting on June 28, 2011, in Houston, Texas, from 10:00 a.m. to 2:00 p.m. (Central Time). Each of these four on-site pre-application meetings will also be transmitted live through the Internet as a webinar. Detailed information on the pre-application meetings, including registration information for the on-site meetings and webinars, specific location information for the on-site meetings, and information on how to notify the Department if an attendee will need special accommodations, is available on the i3 Web site at http://www2.ed.gov/ programs/innovation/index.html. Accessible Format: Individuals with disabilities can obtain this document in an accessible format (e.g., braille, large print, audiotape, or compact disc) on request to the program contact person listed under FOR FURTHER INFORMATION CONTACT. Electronic Access to This Document: The official version of this document is the document published in the Federal Register. Free Internet access to the official edition of the Federal Register and the Code of Federal Regulations is available via the Federal Digital System at: http://www.gpo.gov/fdsys. At this site you can view this document, as well as all other documents of this Department published in the Federal Register, in text or Adobe Portable Document Format (PDF). To use PDF you must have Adobe Acrobat Reader, which is available free at the site. You may also access documents of the Department published in the Federal Register by using the article search feature at: http:// www.federalregister.gov. Specifically, through the advanced search feature at this site, you can limit your search to documents published by the Department. Dated: June 10, 2011. James H. Shelton, III, Assistant Deputy Secretary for Innovation and Improvement. [FR Doc. 2011–14861 Filed 6–14–11; 8:45 am] BILLING CODE 4000–01–P DEPARTMENT OF ENERGY Extension of Scoping Period for the Northern Pass Transmission Line Project Environmental Impact Statement Department of Energy. Reopening of scoping period. AGENCY: ACTION: The U.S. Department of Energy (DOE) is reopening the public SUMMARY: PO 00000 Frm 00017 Fmt 4703 Sfmt 4703 34969 scoping period for the Northern Pass Transmission Line Project Environmental Impact Statement (EIS) (DOE/EIS–0463). In anticipation of additional alternative route information being provided by Northern Pass, DOE is reopening the scoping period. DOE will determine the close of the scoping period once the additional routing information is received from Northern Pass, and DOE will provide at least 45 days for public review and scoping comments on any such routing information. DATES: The reopened public scoping period starts with the publication of this notice in the Federal Register and will remain open until DOE provides further notice of its closing. ADDRESSES: Comments on the scope of the EIS and requests to be added to the document mailing list should be addressed to: Brian Mills, Office of Electricity Delivery and Energy Reliability (OE–20), U.S. Department of Energy, 1000 Independence Avenue, SW., Washington, DC 20585; by electronic mail to Brian.Mills@hq.doe.gov; or by facsimile to 202–586–8008. For general information on the DOE NEPA process contact: Ms. Carol M. Borgstrom, Director, Office of NEPA Policy and Compliance (GC–54), U.S. Department of Energy, 1000 Independence Avenue, SW., Washington, DC 20585; by electronic mail at askNEPA@hq.doe.gov; by facsimile at 202–586–7031; or by phone at 202–586–4600, or leave a message at 800–472–2756. FOR FURTHER INFORMATION CONTACT: For information on DOE’s proposed action, contact Brian Mills by one of the methods listed in ADDRESSES above, or at 202–586–8267. For general information on the DOE NEPA process, contact Ms. Carol M. Borgstrom by one of the methods listed in ADDRESSES above. For information on the Forest Service’s role as a cooperating agency, contact Tiffany Benna by electronic mail at tbenna@fs.fed.us; by phone at 603– 536–6241; by facsimile at 603–536– 3685; or by mail at 71 White Mountain Drive, Campton, NH 03223. For information on the Army Corps of Engineers’ permit process, contact Erika Mark at 978–318–8250; by electronic mail at Erika.L.Mark@usace.army.mil; or by mail at 696 Virginia Road, Concord, MA 01742. For information on the EPA role in the EIS, contact Timothy L. Timmermann by electronic mail at timmermann.timothy@epa.gov; by phone at 617–918–1025; or by mail at 5 Post Office Square, Suite 100, Boston, MA 02109–3912. Information on the EIS also is available at DOE’s Web site for E:\FR\FM\15JNN1.SGM 15JNN1

Agencies

[Federal Register Volume 76, Number 115 (Wednesday, June 15, 2011)]
[Notices]
[Pages 34968-34969]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-14801]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning the Methods 
and Compositions for Treating Status Epilepticus and Seizures Causing 
Status Epilepticus

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in the PCT/US2009/060091, entitled ``Methods and 
Compositions for Treating Status Epilepticus and Seizures Causing 
Status Epilepticus'' filed on October 9, 2009. The United States 
Government, as represented by the Secretary of the Army, has rights to 
this invention. U.S. and selected foreign rights are available.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele, 
Office of Research & Technology Applications, (301) 619-6664. For 
patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301)

[[Page 34969]]

619-7808, both at telefax (301) 619-5034.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2011-14801 Filed 6-14-11; 8:45 am]
BILLING CODE 3710-08-P